Currently, suspected drug overdoses represent more than 1 in 6 death investigations, and both coroner and medical examiner offices are facing overwhelming caseloads that require comprehensive toxicology analysis. Therefore, there is a critical and immediate need to improve the workflow in suspected fatal overdose cases with new postmortem toxicology screening tools. This Phase I project from High Throughput Biology, Inc is to develop an Array-Based Multiplex Immunoassay For Postmortem Toxicology Screening.
Public Health Relevance Statement: Terms: Phase; SBIR; Small Business Innovation Research; screenings; necropsy; postmortem; screening; Small Business Innovation Research Grant; Immunoassay; Autopsy; Toxicology
